Single-use Bioreactors Market

The global single-use bioreactors market is projected to reach USD 9.1 billion by 2029 from USD 4.4 billion in 2024, at a CAGR of 15.4% during the forecast period of 2024 to 2029. Growth in the single-use bioreactors market can be attributed to factors such as growing adoption among CDMOs, CMOs, and SMEs, advantages over conventional bioreactors, reduced capital investment, reduced water and energy consumption, and growing biologics & biosimilars markets. On the other hand, issues related to extractables & leachables, regulatory hurdles and compliance issues, and impact of PFAS restrictions on product development are expected to hinder market growth.

The global single-use bioreactors market is competitive, with Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) and Merck KGaA (Germany) accounting for the 70-80% of the market share globally.

To know about the assumptions considered for the study download the pdf brochure

Sartorius AG provides an extensive range of single-use bioreactor products for end users such as biopharmaceutical & pharmaceutical companies, CMOs, and CROs. The company’s strong focus on a broad range of customer-centric and technology-enabled solutions, significant investments in R&D, and a comprehensive product line comprising high-quality products are contributing to its growing share in the single-use bioreactors market. With a strong geographic presence and continuous expansions in developed and developing regions, the company is expected to grow at a high rate in the single-use bioreactors market during the forecast period.

Danaher Corporation provides cell culture, filtration, separation, and purification technologies for the medical, biopharmaceutical, and food & beverage industries through its subsidiary, Cytiva (a part of the Life Sciences business). The company is one of the top players in the single-use bioreactors market with its strong portfolio of single-use bioreactors solutions. Its bioprocessing single-use technologies facilitate the development and commercialization of chemically synthesized and biologically derived drugs, plasma, and vaccines.

Thermo Fisher Scientific, Inc. offers a broad spectrum of single-use bioreactor products. This wide array allows it to serve diverse market needs effectively. As a leading player with a high market share, it has significant influence over market trends and customer preferences, leveraging its established reputation to maintain leadership. Continuous investment in R&D ensures the company remains at the forefront of technological advancements, addressing emerging challenges and opportunities in bioprocessing.

Related Reports:

Single-Use Bioreactors Market by Product (Systems, Bags, Assemblies), Type (Stirred Tank, Bubble-Column, Wave induced), Molecule (mAbs, Vaccines), Cell Type (Mammalian, Bacterial, Yeast), Application (R&D, Bioproduction) - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]